Sweden
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 3.14 B
|
Dec. 31, 2023 | USD 16.63 | 0.49% |
|
Sweden |
|
2 |
USD 1.08 B
|
Dec. 31, 2023 | USD 3.30 | 3.88% |
|
Sweden |
|
3 |
USD 955.91 M
|
Dec. 31, 2023 | USD 12.08 | 1.50% |
|
Sweden |
|
4 |
USD 346.63 M
|
Dec. 31, 2023 | USD 18.25 | 2.79% |
|
Sweden |
|
5 |
USD 135.52 M
|
Dec. 31, 2023 | USD 0.28 | 0.36% |
|
Sweden |
|
6 |
USD 66.85 M
|
Dec. 31, 2023 | USD 18.76 | 3.89% |
|
Sweden |
|
7 |
USD 56.39 M
|
Dec. 31, 2023 | USD 0.89 | 14.73% |
|
Sweden |
|
8 |
USD 29.11 M
|
Dec. 31, 2023 | USD 19.07 | 4.08% |
|
Sweden |
|
9 |
USD 27.01 M
|
Dec. 31, 2023 | USD 2.19 | 0.18% |
|
Sweden |
|
10 |
USD 16.09 M
|
Dec. 31, 2023 | USD 0.97 | -2.02% |
|
Sweden |
|
11 |
USD 15.19 M
|
Dec. 31, 2023 | USD 1.42 | 3.80% |
|
Sweden |
|
12 |
USD 13.09 M
|
Dec. 31, 2023 | USD 0.47 | 0.81% |
|
Sweden |
|
13 |
USD 8.30 M
|
Dec. 31, 2023 | USD 0.15 | 3.82% |
|
Sweden |
|
14 |
USD 6.21 M
|
Dec. 31, 2023 | USD 0.12 | 3.82% |
|
Sweden |
|
15 |
USD 5.47 M
|
April 30, 2024 | USD 0.14 | 0.68% |
|
Sweden |
|
16 |
USD 3.53 M
|
Dec. 31, 2023 | USD 0.56 | 4.18% |
|
Sweden |
|
17 |
USD 2.29 M
|
Dec. 31, 2023 | USD 0.11 | -0.86% |
|
Sweden |
|
18 |
USD 1.04 M
|
Dec. 31, 2023 | USD 0.94 | 2.12% |
|
Sweden |
|
19 |
USD 24.08 K
|
Dec. 31, 2023 | USD 0.19 | 33.40% |
|
Sweden |
The Medical Instruments company in Sweden with the highest Revenue is Getinge AB (publ) (Stockholm Stock Exchange: GETI-B.ST) at USD 3.14 B.
The Medical Instruments company in Sweden with the lowest Revenue is Qlife Holding AB (publ) (Stockholm Stock Exchange: QLIFE.ST) at USD 24.08 K.
The top 10 Medical Instruments companies in Sweden by Revenue are Getinge AB (publ), Arjo AB (publ), AddLife AB (publ), Vitrolife AB (publ), ADDvise Group AB (publ), CellaVision AB (publ), Boule Diagnostics AB (publ), Stille AB, Mentice AB (publ) and Arcoma AB.
The bottom 10 Medical Instruments companies in Sweden by Revenue are Qlife Holding AB (publ), AcouSort AB (publ), BrainCool AB (publ), Senzime AB (publ), ScandiDos AB (publ), Serstech AB, Ortivus AB (publ), ContextVision AB (publ), Sedana Medical AB (publ) and Arcoma AB.